Brief
Cervical Cancer Diagnosis Startup Biop Raises $2.2 Million
Israel-based Biop develops a device for mapping the cervix and identifying cancerous and precancerous cells in epithelial tissues
15:3617.09.18
Israel-based cervical cancer diagnosis startup Biop Medical Ltd. has raised $2.2 million in a funding round led by South Africa-based medical equipment company Avacare Health Group, the company announced Thursday. As part of the agreement, Avacare will distribute Biop’s device. The company said in a statement it intends to use the funding for research and development, for the expansion of its clinical trials and for completing the FDA approval process.
Biop's team. Photo: PR
Founded in 2013 and based in Ramat Gan, a town in the Tel Aviv area, Biop develops a device for mapping the cervix and identifying cancerous and precancerous cells in epithelial tissues. The company has 10 employees and has raised $4.45 million to date.
Biop's team. Photo: PR
